Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0410
0.00 (0.00%)
Mar 3, 2026, 9:30 AM EST

PLSH Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
23110--
Market Cap Growth
-44.72%151.53%-89.62%---
Enterprise Value
-231818--
Last Close Price
0.040.150.070.72--
PS Ratio
0.881.110.654.92--
PB Ratio
-0.25-0.32-0.491.43--
P/TBV Ratio
---2.09--
EV/Sales Ratio
-9.6811.088.87--
Debt / Equity Ratio
-2.27-2.61-8.852.113.411.57
Net Debt / Equity Ratio
-2.26-2.60-8.321.582.970.74
Net Debt / EBITDA Ratio
-5.97-5.62-4.55-2.66-5.59-4.71
Net Debt / FCF Ratio
-13.40-13.54-6.75-2.74-1.84-0.81
Asset Turnover
0.150.130.080.080.28-
Inventory Turnover
1.631.531.421.021.95-
Quick Ratio
0.020.020.120.450.170.68
Current Ratio
0.230.240.420.900.630.98
Return on Equity (ROE)
---368.81%-69.26%-56.11%-
Return on Assets (ROA)
-18.46%-18.50%-16.33%-13.46%-10.40%-
Return on Capital Employed (ROCE)
178.40%378.70%-128.00%-43.30%-40.10%-15.80%
Earnings Yield
-314.55%-302.89%-869.02%-47.20%--
FCF Yield
-66.55%-60.08%-251.26%-40.31%--
Buyback Yield / Dilution
-18.33%-11.88%16.60%-5.35%4.90%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.